Kazuko Matsuda - 23 Jan 2023 Form 4 Insider Report for MEDICINOVA INC (MNOV)

Role
Chief Medical Officer, Director
Signature
/s/ Yuichi Iwaki, attorney-in-fact
Issuer symbol
MNOV
Transactions as of
23 Jan 2023
Transactions value $
$0
Form type
4
Filing time
25 Jan 2023, 16:16:13 UTC
Previous filing
31 Jan 2022
Next filing
11 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNOV Employee Stock Option (Right to Buy) Award $0 +149,625 $0 149,625 23 Jan 2023 Common Stock 149,625 $2.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 27, 2022, the reporting person was granted an option to purchase 157,500 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. Such performance criteria for 2022 were achieved at the 95% attainment level, resulting in vesting of the option as to 149,625 shares.